Peptide Therapeutics Market was valued at US $35.68 billion in 2021 and is projected to grow at 7.16% CAGR over the forecast period to reach US $54.02 billion by 2027. Peptide Therapeutics Market represented US $4.61 billion opportunity over 2019-2021 and estimated to create US $18.34 billion opportunity in 2027 over 2021.
Peptide Therapeutics from Consainsights analyses the Peptide Therapeutics Market in the Life Sciences industry over the forecast period to 2027.
Peptide Therapeutics research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.
Peptide Therapeutics segmentation includes Marketing Type, Application, Route of Administration and Geography.
Based on the Marketing Type, the Peptide Therapeutics analysis covers Branded, Generic.
In Marketing Type segment, Branded segment has highest cagr growth of 6.34%.
Based on the Application, the Peptide Therapeutics analysis covers Cancer, Other Applications, Metabolic Disorders, Neurological Disorders, Gastrointestinal Disorders.
In Application segment, Cancer segment has highest cagr growth of 6.34%.
Based on the Route of Administration, the Peptide Therapeutics analysis covers Oral, Parenteral, Other Routes of Administration.
In Route of Administration segment, Oral segment has highest cagr growth of 6.34%.
Based on the region, the Peptide Therapeutics analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.
Key companies operating in the market include Sanofi SA, Amgen Inc., Novartis AG, Pfizer Inc., AmbioPharm Inc., AstraZeneca PLC, Novo Nordisk AS, PeptiDream Inc., Arch NioPartners, Bachem Holding AG, CirclePharma Inc., PolyPeptide Group, Zealand Pharma AG, Apitope Technology, GlaxoSmithKline PLC, Eli Lilly and Company, Amylin Pharmaceuticals, Ever Neuro Pharma GmbH, Galena Biopharmaceuticals, Bristol-Myers Squibb Company, Teva Pharmaceuticals Industries Ltd, Takeda Pharmaceutical Company Limited and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.